価格表

在庫・価格 : 2025年04月27日 05時53分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
AFP, Human, ELISA Kit, Quantikine (96 well)
データシート※最新のデータシートでない場合があります
DAFP00 RSDアールアンドディー システムズ
R&D Systems, Inc.
1 kit ¥116,000
(未発注)
追加

在庫・価格 : 2025年04月27日 05時53分 現在

AFP, Human, ELISA Kit, Quantikine (96 well)

  • 商品コード:DAFP00
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Tanaka Y et al. A novel approach and protocol for discovering extremely low-abundance proteins in serum. Proteomics 2006 Sep;6(17):4845-55
Tanaka Y et al
2006/01/01
Sample Type: Serum PubMed
2 Wu FX et al. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy. Cancer Lett. 2009 Jul;279(2):163-70
Wu FX et al
2009/01/01
Sample Type: Serum PubMed
3 Kwon OJ et al. A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas. Clin. Cancer Res. 2010 Dec;16(24):6071-82
Kwon OJ et al
2010/01/01
Sample Type: Serum PubMed
4 Buhimschi CS et al. Proteomics mapping of cord blood identifies haptoglobin "switch-on" pattern as biomarker of early-onset neonatal sepsis in preterm newborns. PLoS ONE 2011;6(10):e26111
Buhimschi CS et al
2011/01/01
Sample Type: Serum PubMed
5 Falix FA et al. DLK1, a serum marker for hepatoblastoma in young infants. Pediatr Blood Cancer 2012 Oct;59(4):743-5
Falix FA et al
2012/01/01
Sample Type: Serum PubMed
6 Dudek H et al. Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo. Mol. Ther. 2014 Jan;22(1):92-101
Dudek H et al
2014/01/01
Sample Type: Serum PubMed
7 Miyoshi T et al. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias. Am. J. Obstet. Gynecol. 2019 Jan;220(1):104.e1-104.e15
Miyoshi T et al
2019/01/01
PubMed
8 Hwang HM et al. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma. J Transl Med 2018 Jun;16(1):177
Hwang HM et al
2018/01/01
PubMed
9 Wang ZF et al. Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma. Oncol Lett 2018 Aug;16(2):1593-1601
Wang ZF et al
2018/01/01
PubMed
10 Kamimura K et al. Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma. Cancers (Basel) 2020 Feb;12(2)
Kamimura K et al
2020/01/01
Species: Mouse PubMed
11 Yang W et al. Protein kinase 2 (CK2)&#xA0;controls CD4<sup>+</sup> T cell effector function in the pathogenesis of colitis. Mucosal Immunol 2020 09;13(5):788-798
Yang W et al
2020/01/01
Species: Mouse, Applications: Flow Cytometry PubMed
  • No.: 1
  • 文献情報:
    Tanaka Y et al. A novel approach and protocol for discovering extremely low-abundance proteins in serum. Proteomics 2006 Sep;6(17):4845-55
    Tanaka Y et al
    2006/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wu FX et al. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy. Cancer Lett. 2009 Jul;279(2):163-70
    Wu FX et al
    2009/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kwon OJ et al. A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas. Clin. Cancer Res. 2010 Dec;16(24):6071-82
    Kwon OJ et al
    2010/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Buhimschi CS et al. Proteomics mapping of cord blood identifies haptoglobin &quot;switch-on&quot; pattern as biomarker of early-onset neonatal sepsis in preterm newborns. PLoS ONE 2011;6(10):e26111
    Buhimschi CS et al
    2011/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Falix FA et al. DLK1, a serum marker for hepatoblastoma in young infants. Pediatr Blood Cancer 2012 Oct;59(4):743-5
    Falix FA et al
    2012/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Dudek H et al. Knockdown of &#x3B2;-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo. Mol. Ther. 2014 Jan;22(1):92-101
    Dudek H et al
    2014/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Miyoshi T et al. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias. Am. J. Obstet. Gynecol. 2019 Jan;220(1):104.e1-104.e15
    Miyoshi T et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hwang HM et al. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma. J Transl Med 2018 Jun;16(1):177
    Hwang HM et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wang ZF et al. Serum long noncoding RNA LRB1 as a potential biomarker for predicting the diagnosis and prognosis of human hepatocellular carcinoma. Oncol Lett 2018 Aug;16(2):1593-1601
    Wang ZF et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kamimura K et al. Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma. Cancers (Basel) 2020 Feb;12(2)
    Kamimura K et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yang W et al. Protein kinase 2 (CK2)&#xA0;controls CD4<sup>+</sup> T cell effector function in the pathogenesis of colitis. Mucosal Immunol 2020 09;13(5):788-798
    Yang W et al
    2020/01/01
  • 備考:
    Species: Mouse, Applications: Flow Cytometry
  • 参照:
    PubMed